AIMS SIG - Open-Source Lunch Bites
Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry.
Session presentations can be found below. They are listed by date and session title, with slide decks available to download beneath.
Please note: these are only accessible for PSI Members, and you will need to be signed in to access them.
Keynote
Geert Meulenbergs - Biostatistics in a post-pandemic era
Estimands for time-to-event outcomes
1. Looking back on our estimands in oncology working group journey - Evgeny Degtyarev
2. Re-Thinking treatment effect measure in clinical trials with time-to-event outcomes and competing risks- Tobias Mutze
3. Outcome of Survey on Current Standards and Implementation of Covariate Adjusted and Stratified Analyses - Sarwar Mozumder
4. Can the Estimand framework help improve the analysis of adverse events of special interest - Pedro Lopez Romero
Biomarkers ESIG
Biomarkers ESIG - Advancing Biomarker Insights in Precision Medicine and Digital Health
Patient Focused Drug Development (PFDD) SIG: Hot Topics
1. Patient Focused Drug Development Hot Topics - Rachael Lawrance
2. PFDD - Konstantina Skaltsa
3. PFDD - Emerging Patient-Centric Tolerability Endpoints - John Devin Peipert
4. PFDD Patient Focussed Digital Health Technology - Piper Fromy
How to Generate Evidence from Real World Data
1. Transforming RWD into RWE overview
2. External control cohorts for the single-arm LIBRETTO-001 trial - Min Hua Jen
Causal inference and estimands
1. Targetted maximum likelihood estimation - Bob Murray
2. Estimand in Formulation Studies - Insight from IMscin trial - Mahesh Shivhare
3. Estimands and complex innovative designs - Olivier Collignon
4. Causal inference and estimands - Yongming Qu
Data Visualization and animation
1. How to draw a really bad graph - Chris Harbron
2. Digital accessibility - Ursula Becker
3. Data Story Telling - Bodo Kirsch
HTA
1. Enhanced subgroup identification in heterogeneous clinical courses of disease burden using a machine learning score from CT images - Grace Kim
2. Developing Trial-Based Risk Prediction Models - Milans Ivkovic and Martin Bog
3. Open source workflows for HTA - Anders Gorst-Rasmussen
4. Censoring and choice of Tau in Quality Adjusted Time Without Symptoms of Toxicity - Saiful Islam and Grace Antony
CYS2
1. Enhancing Variable Importance Interpretation - Ahmad Chamma
2. Time patterns of repeat non-fatal events and death in heart failure trials - Audinga-Dea Hazewinkel
3. Rise n Shiny - Taking steps to utilise R packages in Shiny applications - Emily Foreman
4. Accounting for the recruitment process - Marco Ratta
Keynote
Theo Smith - Neurodiversity at work
Quantitative Decision Making in Drug Development
1. Simple approaches for portfolio quantitative decision-making session - Gaelle Saint-Hilary
2. Simple approaches for portfolio quantitative decision-making session - Rosalind Hobson
3. Simple approaches for portfolio quantitative decision-making session - Wei Quan